Heart Watch Study: protocol for a pragmatic randomised controlled trial.

ABSTRACT:

Introduction

Personal digital devices that provide health information, such as the Apple Watch, have developed an increasing array of cardiopulmonary tracking features which have received regulatory clearance and are directly marketed to consumers. Despite their widespread and increasing use, data about the impact of personal digital device use on patient-reported outcomes and healthcare utilisation are sparse. Among a population of patients with atrial fibrillation and/or atrial flutter undergoing cardioversion, our primary aim is to determine the impact of the heart rate measurement, irregular rhythm notification, and ECG features of the Apple Watch on quality of life and healthcare utilisation.

Methods and analysis

We are conducting a prospective, open-label multicentre p

SUBMITTER: Dhruva SS 

PROVIDER: S-EPMC8719216 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature